2 completed, 1 terminated. 2 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Terminated 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow Daniela Moga: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Medication Optimization in Rural Kentucky Appalachian Patients With Mild Cognitive Impairment or Dementia Medication therapy management - Dementia, Mild Cognitive Impairment | Not applicable | Terminated | Daniela Moga | 16 | 2021-10-14 | 2024-08-23 |
| The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression Placebo, Medication Therapy Management (MTM), Scopolamine patch - Alzheimer's Disease, Dementia | Early Phase 1 | Completed | Daniela Moga | 90 | 2017-04-04 | 2023-07-19 |
| A Pilot Study to Reduce Inappropriate Anticholinergic Prescribing in the Elderly Arm 1 Education Session - Alzheimer Disease | Not applicable | Completed | Daniela Moga | 50 | 2014-09-01 | 2019-03-29 |
Alzheimer Disease (3) · Dementia (2) · Cognitive Dysfunction (1)
Medication Therapy Management (2) · Methods (1)
United States (3)
PMID 28535785, PMID 31888732, PMID 36281668, PMID 36894900
R01AG054130 (1), R24AG064025 (1)